Continuous Glucose Monitoring in Intensive Care Unit
NCT: NCT05585801 · ACTIVE_NOT_RECRUITING
Brief Summary
Glucose control in ICU patients is challenging and exerts high burden on the nursing staff. Continuous glucose monitors (CGM) are now approved and widely available in the outpatient setting for patients with diabetes mellitus. However, only minimal evidence on CGM performance, reliability and benefit in achieving desired glucose control in the intensive care setting has been gathered so far. The objective of this study is to assess whether the use of CGM helps to maintain blood glucose levels within the time in range recommended for patients in the intensive care. In addition, accuracy of the sensor will be evaluated and compared to measurements of blood glucose by standardized biochemistry methods.
Frequently Asked Questions
What is Continuous Glucose Monitoring in Intensive Care Unit?
Continuous Glucose Monitoring in Intensive Care Unit is a clinical trial registered under NCT05585801. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05585801?
The current status of NCT05585801 (Continuous Glucose Monitoring in Intensive Care Unit) is: ACTIVE_NOT_RECRUITING.
When did Continuous Glucose Monitoring in Intensive Care Unit start?
Continuous Glucose Monitoring in Intensive Care Unit started on 2022-11-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.